Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumor model.

A spatio-temporal model of tumor response to sequestered, intracellular doxorubicin is presented and simulated. An important feature of the model is the characterization of different mechanisms by which doxorubicin initiates the cell death cascade. The model predicts that the long-term response of the tumor to repeated rounds of therapy is very sensitive to changes in the threshold level of doxorubicin required to initiate apoptosis at the maximum rate. In fact, perturbations of this parameter mediate the difference between effective tumor regression and minimal growth delays. The model is also used to investigate which parameters are most influential in rendering the tumor drug resistant. Sensitivity analysis shows that decreasing cellular permeability, as opposed to decreasing sequestration rate or increasing cellular efflux, is the most effective way for tumor cells to overcome the growth control afforded by successive rounds of treatment.

[1]  H M Byrne,et al.  A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy. , 2000, Mathematical biosciences.

[2]  H. Svensson,et al.  In Vitro and In Vivo Activities of a Doxorubicin Prodrug in Combination with Monoclonal Antibody β-Lactamase Conjugates , 1995 .

[3]  G. Lui,et al.  Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells , 2004, Cancer Chemotherapy and Pharmacology.

[4]  J. Winter,et al.  Decreased intracellular compartmentalization of doxorubicin in cell lines expressing P-glycoprotein. , 1994, Journal of Pharmacology and Experimental Therapeutics.

[5]  J. Winter,et al.  Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs. , 1995, Cytometry.

[6]  I. Herr,et al.  The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. , 1997, Cancer research.

[7]  A. Andreoni,et al.  Fluorometric determination of the kinetics of anthracyclines uptake by cells. , 1994, Journal of biochemical and biophysical methods.

[8]  F. Gieseler,et al.  Cytotoxicity of anthracyclines: Correlation with cellular uptake, intracellular distribution and DNA binding , 2005, Annals of Hematology.

[9]  N. Siemers,et al.  Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation. , 1997, Bioconjugate chemistry.

[10]  J. Winter,et al.  Kinetic analysis of P-glycoprotein-mediated doxorubicin efflux. , 1992, The Journal of pharmacology and experimental therapeutics.

[11]  M. Dalmark,et al.  A Fickian diffusion transport process with features of transport catalysis. Doxorubicin transport in human red blood cells , 1981, The Journal of general physiology.

[12]  T. Suuronen,et al.  Distinct mode of apoptosis induced by genotoxic agent etoposide and serum withdrawal in neuroblastoma cells. , 1998, Brain Research. Molecular Brain Research.

[13]  T L Jackson,et al.  Theoretical analysis of conjugate localization in two-step cancer chemotherapy , 1999, Journal of mathematical biology.

[14]  T. Landowski,et al.  Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line , 2000, Leukemia.

[15]  W. Deen.  Hindered transport of large molecules in liquid‐filled pores , 1987 .

[16]  M. Chaplain,et al.  Free boundary value problems associated with the growth and development of multicellular spheroids , 1997, European Journal of Applied Mathematics.

[17]  D. Braguer,et al.  Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'. , 2000, Cancer research.

[18]  P. Trail,et al.  Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. , 1997, Cancer research.

[19]  R. Jain,et al.  Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data. , 1996, British Journal of Cancer.

[20]  R K Jain,et al.  Extravascular diffusion in normal and neoplastic tissues. , 1984, Cancer research.

[21]  E. Demant,et al.  Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding. , 1998, Biochemical pharmacology.

[22]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.

[23]  R. Begent,et al.  First clinical experience with ADEPT , 1996 .

[24]  G. Schreiber,et al.  Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs. , 1995, Cancer research.

[25]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[26]  V. Ling,et al.  P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  H M Byrne,et al.  Growth of nonnecrotic tumors in the presence and absence of inhibitors. , 1995, Mathematical biosciences.

[28]  Trachette L. Jackson,et al.  Vascular tumor growth and treatment: Consequences of polyclonality, competition and dynamic vascular support , 2002, Journal of mathematical biology.

[29]  Trachette L. Jackson,et al.  Development and validation of a mathematical model to describe anti-cancer prodrug activation by antibody-Enzyme conjugates , 2000 .

[30]  G. Gahrton,et al.  Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells , 2004, Cancer Chemotherapy and Pharmacology.

[31]  R. Ozols,et al.  The anthracycline antineoplastic drugs. , 1981, The New England journal of medicine.

[32]  S. Fulda,et al.  Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells. , 2000, Blood.

[33]  M. Chaplain,et al.  Modelling the role of cell-cell adhesion in the growth and development of carcinomas , 1996 .

[34]  J. C. Mason,et al.  Osmotic reflextion coefficients of capillary walls to low molecular weight hydrophilic solutes measured in single perfused capillaries of the frog mesentery. , 1976, The Journal of physiology.

[35]  Rakesh K. Jain,et al.  Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.